Quarterly ResultMay 7, 2026, 04:33 PM
ICU Medical Q1 Net Income $30.1M; EPS $1.22; Revenue $530.2M
AI Summary
ICU Medical reported a net income of $30.1 million, or $1.22 per diluted share, for the first quarter of 2026, a significant improvement from a net loss of $15.5 million, or $(0.63) per diluted share, in the prior year. Total revenues decreased by 12.3% to $530.2 million, primarily due to the divestment of a 60% ownership interest in its IV Solutions business in May 2025. The company also noted an immaterial divestiture of certain assets in March 2026.
Key Highlights
- Net income was $30.1 million ($1.22 diluted EPS) in Q1 2026, up from a net loss of $15.5 million ($(0.63) diluted EPS) in Q1 2025.
- Total revenues decreased 12.3% to $530.2 million in Q1 2026 from $604.7 million in Q1 2025.
- Gross profit was $206.2 million in Q1 2026, a 1.8% decrease from $210.1 million in Q1 2025.
- Income from operations increased 5.4% to $13.6 million in Q1 2026 from $12.9 million in Q1 2025.
- Consumables revenue increased to $278.3 million in Q1 2026 from $266.2 million in Q1 2025.
- Infusion Systems revenue increased to $179.6 million in Q1 2026 from $166.3 million in Q1 2025.
- Vital Care revenue decreased to $72.3 million in Q1 2026 from $172.2 million in Q1 2025, impacted by divestment.
- Net cash provided by operating activities was $38.9 million in Q1 2026, down from $51.3 million in Q1 2025.
Price Impact
More from ICUI